{
    "organizations": [],
    "uuid": "7ea338b1ba9c1284f224817977df8c6a63d1d024",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-precipio-responses-to-articles-on/brief-precipio-responses-to-articles-on-its-approach-using-ice-cold-pcr-liquid-biopsy-tests-on-real-time-pcr-platforms-idUSFWN1RG0FN",
    "ord_in_thread": 0,
    "title": "BRIEF-Precipio - Responses To Articles, On Its Approach Using Ice Cold-Pcr Liquid Biopsy Tests On Real Time Pcr Platforms ‍​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 3 (Reuters) - Precipio Inc:\n* PRECIPIO - RESPONSES TO ARTICLES, ON ITS APPROACH USING ICE COLD-PCR LIQUID BIOPSY TESTS ON REAL TIME PCR PLATFORMS ‍​ Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)\n ",
    "published": "2018-04-03T20:03:00.000+03:00",
    "crawled": "2018-04-04T12:16:02.016+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "precipio",
        "inc",
        "precipio",
        "response",
        "article",
        "approach",
        "using",
        "ice",
        "liquid",
        "biopsy",
        "test",
        "real",
        "time",
        "pcr",
        "platform",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}